AGA Research Foundation pilot awards are an invaluable tool for investigators, because they provide seed funding to explore promising new lines of research and generate preliminary data for larger grants. So, when David L. Boone, PhD, received the 2017 AGA-Pfizer Young Investigator Pilot Research Award in Inflammatory Bowel Disease from the AGA Research Foundation, he was able to double-down on a very targeted project studying innate immunity in inflammatory bowel disease (IBD). Based on his recent accomplishments — both in and out of the laboratory — we are excited for you to get to know Dr. Boone, associate professor of microbiology and immunology at the Indiana University School of Medicine-South Bend and our AGA Research Foundation researcher of the month.
Bench to bedside: Working toward new treatment options in IBD
The Boone Laboratory AGA-funded project is specifically focused on JAK inhibitors, which are becoming a more popular treatment option for patients with IBD, especially for those patients whose disease does not respond to anti–tumor necrosis factor therapy. Dr. Boone is committed to enhancing our understanding of how these JAK inhibitors work on a cellular level. If we can understand this, Dr. Boone is optimistic it will lead to new approaches for treating inflammation in IBD.
With his AGA Research Foundation grant, Dr. Boone and his laboratory characterized a new robust mouse model of colitis that is entirely driven by innate immune mechanisms. With this model, his team is investigating the cellular and molecular mechanisms that drive innate immune-mediated inflammation in the intestine in the hopes that it will provide important insights for future IBD drug development. You can read the specifics of Dr. Boone’s research in his recently published work in Mucosal Immunology.
Pilot award provides a stepping stone
Dr. Boone’s AGA Research Foundation pilot grant has paved the way for future success. Using the data from his AGA-funded project, as well as the constructive feedback he received from the AGA awards panel, Dr. Boone went on to successfully obtain new funding in the form of a Pfizer ASPIRE research grant. This work is building the foundation for Dr. Boone’s next big grant venture: an NIH R01 grant.
Two postdocs, a graduate student, a technician and a dog named Boone
Dr. Boone shared with us that the best outcome from his AGA grant was that the additional funding made it possible to grow his laboratory by a postdoctoral researcher and laboratory technician. One of Dr. Boone’s great passions is training the next generation of scientists, both in the laboratory and through his role as microbiology and immunology professor for first-year medical students at Indiana University School of Medicine.
It’s clear that Dr. Boone has made a lasting impact on his former mentees and students. One of his former postdoctoral researchers named her Labrador retriever “Boone” in his honor (hence, Boone Lab). In an ironic turn of events, Boone the dog is currently being treated with a JAK inhibitor for an inflammatory condition!
Beyond the laboratory: A commitment to patients with IBD
Dr. Boone wanted to do more to support patients with IBD. He had heard of Camp Oasis- the Crohn’s & Colitis Foundation regional camp for patients with IBD – and knew of physicians who provided medical services at the camp. After looking into making a donation to Camp Oasis Michigan, Dr. Boone learned that what the camp really needed was male counselors. So, despite being “older than an average camp counselor,” Dr. Boone packed his bags for Michigan. Participating in Camp Oasis the last two years has been a great joy for Dr. Boone and provides added inspiration and motivation for his work in the laboratory.